O

Outlook Therapeutics
D

OTLK

6.53000
USD
0.19
(3.00%)
Market Open
Volume
1,324
EPS
0
Div Yield
0
P/E
-1
Market Cap
154,471,303
OverviewSignalsIdeasNews
Related Instruments
    A
    ABEO
    -0.10000
    (-2.04%)
    4.80000 USD
    B
    BCLI
    -0.01260
    (-3.67%)
    0.33030 USD
    C
    CRIS
    -0.60000
    (-11.05%)
    4.83000 USD
    F
    FENC
    -0.21700
    (-3.35%)
    6.26300 USD
    L
    LGVN
    -0.10000
    (-3.18%)
    3.04000 USD
    N
    NUZE
    -0.67000
    (-11.26%)
    5.28000 USD
    S
    SNDX
    -0.750
    (-3.30%)
    21.990 USD
News

Title: Outlook Therapeutics

Sector: Healthcare
Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.